Gilead is a California-based biopharmaceutical company that develops and commercializes antiviral drugs to treat diseases in areas such as virology, oncology and inflammation... Read more
Gilead is a California-based biopharmaceutical company that develops and commercializes antiviral drugs to treat diseases in areas such as virology, oncology and inflammation... Read more
News
New Office
Sep 09, 2026
Pharmaceutical Business Review
Gilead launches research facility in US for new medicine development
Conference Presentation
Aug 26, 2026
Yahoo
Gilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences
Regulatory
Aug 25, 2026
Zacks
EC Approves Label Expansion of GILD's Trodelvy in First-line Metastatic TNBC
AI
Aug 11, 2026
Marketscreener
Nucleai And Gilead Sciences Advance AI-Powered Tissue Intelligence Through Large-Scale Oncology ADC Collaboration
Funding
Apr 13, 2026
Pulse2.0
Gilead Sciences received undisclosed amount in Post-IPO Equity Funding
Partnership
Apr 09, 2026
Marketscreener
Tempus AI, Inc. And Gilead Sciences, Inc. Announce Strategic Collaboration To Advance Oncology R&D
Acquisition
Mar 24, 2026
Investing.com
Gilead Sciences acquired Ouro Medicines for $1.7B
investment
Sep 21, 2025
https://www.citybiz.co/article/748043/ensoma-announces-53-million-financing/
Gilead Sciences, Inc. has invested $53M in Ensoma, Inc.
Gilead Sciences Competitors
1
2
3
4
5
6
7
8
9
10